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Competition for nutrients is a key factor controlling pathogen colonization within the gastrointestinal tract. In
this issue, Ferreyra et al. (2014) and Curtis et al. (2014) show that diverse enteric pathogens can exploit a
metabolic byproduct from the commensal microbiota, succinate, to enhance their own virulence expression
and proliferation.The human large intestine is home to a
complex and dynamic consortium of mi-
crobes, also known as the microbiota.
Akin to a physiologic organ, the micro-
biota fulfils many important functions to
maintain host health, including nutrition
acquisition, immune development, and
pathogen defense. Among the most
well-studied functions of the microbiota
is its tremendous metabolic capacity.
Themicrobiota contributes to the produc-
tion of vitamins (e.g., vitamins K and B12
and folic acid), enhances ionic absorption
of calcium and magnesium, and is indis-
pensable for energy salvage from nutri-
ents otherwise nondigestible by human
cells (Gill et al., 2006). Interestingly, while
some metabolic activities of the micro-
biota such as methanogenesis or oxalate
degradation may vary widely between
different individuals, the ability to ferment
nondigestible carbohydrates and proteins
is highly conserved among those func-
tions encoded by the human core micro-
biome (Qin et al., 2010).
The principle end products of bacterial
metabolism in the large intestine are
short-chain fatty acids (SCFAs), which
mainly arise from anaerobic fermentation
of nondigestible carbohydrates. In the
large bowel, these consists of nonstarch
polysaccharides (e.g., dietary fiber and
plant polysaccharides including celluloseand pectin), resistant starch, simple car-
bohydrates not yet digested in the small
intestine, as well as those derived from
sloughed goblet cells and host mucin
glycoproteins. As small (1- to 6-carbon)
organic fatty acids, SCFAs are readily ab-
sorbed and metabolized by the intestinal
mucosa and the liver, where they play a
substantial role in host nutrition (Macfar-
lane and Macfarlane, 2003). SCFAs can
also modulate the intestinal immune
response, such as by inhibiting excessive
proinflammatory cytokines in chronic
inflammation (Smith et al., 2013), and
exert a direct trophic effect on the intesti-
nal epithelium. While the beneficial effect
of microbiota-associated metabolites,
particularly SCFAs, to the host has been
a subject of intense research, how these
substrates influence bacterial-bacterial
interactions is less well understood.
The metabolic landscape of the gut can
vary greatly depending on the microbiota
structure, intestinal transit time, and avail-
ability of fermentable substrates. How-
ever, butyrate (C4), propionate (C3), and
acetate (C2) are typically the most abun-
dant and together make up over 80%
of total SCFAs produced during health
(Macfarlane and Macfarlane, 2003).
These molecules generally arise from
oxidative metabolism of hexose sugars
(e.g., glucose and fructose) through thenearly ubiquitous Embden-Meyerhof
glycolysis pathway. Other SCFAs such
as valerate, formate, and isobutyrate are
products of branched-chain amino acid
metabolism and exist in much lower
levels, while lactate, ethanol, and succi-
nate are metabolic intermediates that
are converted to other SCFAs to various
degrees depending on the extent of mi-
crobial cross-feeding within the intestinal
microenvironment. Therefore, these inter-
mediates are rarely present at significant
levels in the gut. Interestingly, succinate
has been found to accumulate during
intestinal inflammation, such as in antibi-
otic-associated diarrhea and infection
with the pathogen Clostridium difficile in
human and mice (Lawley et al., 2012),
although its role in disease pathogenesis
is still unclear.
In this issue of Cell Host & Microbe, two
studies by Ferreyra et al. (2014) and Curtis
et al. (2014) present important mecha-
nistic insights into the role of succinate in
commensal-pathogen interactions within
the competitive gut ecosystem. Impor-
tantly, both studies provide compelling
evidence to suggest that intestinal metab-
olites inducedbyacommensal bacterium,
Bacteroides thetaiotaomicron, can unex-
pectedly enhance pathogen virulence
expression and colonization in the gut,











Figure 1. Interplay between Commensal-Derived Metabolites and
Pathogen Colonization
The intestinal metabolic environment is typically dominated by the common
SCFAs butyrate, propionate, and acetate. Succinate is a major product
excreted by Bacteroides spp., but it is typically consumed by secondary
fermentative microbes and therefore rarely accumulates to appreciable level,
unless during inflammatory conditions or antibiotic treatment. During infec-
tion, C. difficile can couple the conversion of succinate to butyrate with the
fermentation of dietary carbohydrates such as sorbitol, thereby enhancing
its growth and colonization. At the same time, succinate promotes gluconeo-
genetic metabolism in enterohemorrhagic E. coli (EHEC) and C. rodentium.
This can drive expression of their virulence genes, including those involved
in the formation of attaching-effacing lesions. Thus, phylogenetically diverse
enteric pathogens can subvert a commensal-derived metabolite for coloniza-
tion and virulence.
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is a Gram-negative obligate
anaerobe, which possesses
an arsenal of enzymes to
degrade complex polysac-
charides. Among other
Bacteroides species, B. the-
taiotaomicron can readily pro-
duce SCFAs as well as
convert hostmucin into succi-
nate andacetate,which in turn
allows the production of
butyrate by other secondary
fermentative microbes (Fisch-
bach and Sonnenburg, 2011).
Thus, B. thetaiotaomicron ex-
emplifies a commensal sym-
biont well-adapted to survive
within and to support the in-
testinal metabolic network.
Curtis et al. (2014) ob-
served that in the presence
of B. thetaiotaomicron, the
human pathogen enterohe-
morrhagic E. coli dramatically
upregulates the expression of
numerous virulence factors,including those encoded by the locus of
enterocyte effacement (LEE) pathoge-
nicity island. Interestingly, this transcrip-
tional regulation is driven by a sugar-
sensing mechanism, controlled by the
catabolite repressor/activator protein
Cra (Njoroge et al., 2012). Under
nutrient-rich conditions where glycolytic
catabolites (e.g., glucose and fructose)
are plentiful, Cra is inhibited from binding
to and activating the transcription of ler,
the master regulatory gene of the LEE. In
glucose-poor environments, however,
E. coli can switch to utilizing gluconeo-
genic substrates such as lactate, succi-
nate, and glycerate. Meanwhile in these
gluconeogenic conditions, Cra can bind
to the ler promoter and enhance expres-
sion of the LEE genes. This is thought
to be an important virulence mechanism
for E. coli to establish colonization at the
intestinal mucosa and attach to the host
epithelial surface, where glucose is far
less abundant than in the gut lumen.
Thus, the finding by Curtis et al. (2014)
indicates that sensing of metabolites pro-
duced by the commensalB. thetaiotaomi-
cron can direct virulence and colonization
potential of a pathogen.
Using the Citrobacter rodentium infec-
tion model in mice, which mimics human
E. coli infection, the authors further identi-704 Cell Host & Microbe 16, December 10, 20fied succinate as a key metabolite during
pathogenesis in vivo. In the presence of
B. thetaiotaomicron, succinate level rises
significantly duringC. rodentium infection.
This in turn enhances the expression of
C. rodentium virulence genes such as ler
and eae, responsible for the formation of
attaching-effacing lesions on epithelial
cells that are central to C. rodentium
pathogenicity. Accordingly, mice infected
with C. rodentium experienced a greater
morbidity and more severe intestinal pa-
thology when their microbiota had first
been colonized by B. thetaiotaomicron.
Moreover, this effect was not associated
with a higher density of C. rodentium in
the gut, but rather an increase in its viru-
lence and a greater loss of various protec-
tive mucosal mechanisms such as the
production of mucin and antimicrobial
peptides.
Ferreyra et al. (2014) studied the major
metabolic pathways employed by another
intestinal pathogen, Clostridium difficile,
in the presence of B. thetaiotaomicron.
C. difficile infection is an important cause
of antibiotic-associated diarrhea world-
wide and typically occurs when the indig-
enous microbiota is severe disturbed by
antibiotic exposure (Lawley et al., 2012).
In this study, the authors used a simplified
gnotobiotic mouse model, in which mice14 ª2014 Elsevier Inc.were either monocolonized
with each bacterial species
or both C. difficile and
B. thetaiotaomicron. In addi-
tion, mice were fed with a
normal (polysaccharide-rich)
diet or a polysaccharide-defi-
cient diet in order to shift the
metabolic landscape of the
gut. Similarly to the observa-
tions made in E. coli, Ferreyra
et al. (2014) noted that
C. difficile was able to
respond rapidly to the avail-
ability of carbohydrates in
the gut and the presence
of B. thetaiotaomicron by
changing its own metabolic
programs. Consistent with




tion led to enhanced meta-
bolism of sialic acid by
C. difficile. Sialic acids are
monosaccharides naturallyoccurring at the end of host mucin mole-
cules and epithelial cell surfaces that
can be released enzymatically by Bacter-
oides spp. Thus, C. difficile has evolved a
strategy to utilize a nutrient derived from
host-commensal interactions to enhance
its own colonization.
Furthermore, when polysaccharides
are abundant and in the presence of
competition by B. thetaiotaomicron,
C. difficile switches on alternative meta-
bolic pathways allowing the utilization of
sorbitol and fructose and the conver-
sion of Bacteroides-produced succinate
to butyrate. Importantly, induction of
the succinate-to-butyrate pathway also
promotes proliferation and host coloniza-
tion byC. difficile. This is demonstrated by
the observation that given an abundance
of succinate in the gut, aC. difficilemutant
lacking the succinate transporter could
not colonize to similarly high density as
wild-typeC. difficile. Interestingly, in addi-
tion toC. difficile-induced diarrhea, Ferre-
yra et al. (2014) found that succinate also
accumulates during antibiotic treatment
and during polyethylene-glycol-induced
osmotic diarrhea. Thus, succinate utiliza-
tion may represent a common beneficial
strategy for pathogens to expand in
a competitive gut ecosystem during
different perturbations to the microbiota.
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PreviewsIntestinal pathogens are well known to
exploit the host inflammatory response or
host-derived metabolic byproducts to
outcompete other microbes and estab-
lish colonization. Here, Ferreyra et al.
(2014) and Curtis et al. (2014) both found
that a commensal-derived metabolite,
succinate, can also directly benefit
diverse pathogens belonging to the
Firmicutes (C. difficile) and the Proteo-
bacteria (EHEC and C. rodentium) phyla
(Figure 1). Thus, although the commensal
microbiota often plays a fundamental
role in colonization resistance against
invading pathogens, enteric pathogens
also have evolved different strategies to
exploit metabolic intermediates available
in the inflamed gut for their own advan-
tage (Keeney and Finlay, 2011). Together,
this work represents valuable insight
into the function of microbiota-derivedmetabolites, which can guide the
development of approaches to atten-
uate pathogen virulence or colonization
by modulating the intestinal metabolic
pathways.REFERENCES
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Early during infection, the malaria parasite invades liver cells and undergoes robust replication, generating
thousands of new parasites within days. In this issue of Cell Host & Microbe, Itoe et al. (2014) show that para-
site replication in the liver depends on the synthesis of host bulk phospholipids, which are incorporated into
the expanding parasite and surrounding vacuolar membranes.Many microbial pathogens have evolved
strategies for surviving and replicating
within host cells. While an intracellular
niche offers some sanctuary from the
host immune system, intracellular patho-
gens face the challenge of scavenging
all of their essential nutrients and carbon
sources from the host cell. Many patho-
gens achieve balanced growth within their
intracellular niche by greatly reducing
their overall growth rate. However, a few
pathogens have evolved strategies for
commandeering host nutrients and meta-
bolic precursors in a way that allows high
growth rates within their respective hostcells. A spectacular example of this
is the liver stage of the malaria parasite
(Prudeˆncio et al., 2006). Infection of the
liver by this parasite occurs immediately
after injection of Plasmodium sporozoite
stages into the skin of the mammalian
host by themosquito vector and is an obli-
gate step in the development of clinical
infection. Following invasion of a liver he-
patocyte, the parasite is surrounded by
a vacuolar membrane, generating an
intracellular compartment in which the
parasite undergoes a burst of nuclear
replication and daughter cell formation.
In the case of the human malaria parasite,Plasmodium falciparum, infection of a
single hepatocyte gives rise to 10,000–
30,000 new parasites (merozoites) over 5
to 6 days. These parasite progeny are
released from their vacuolar compart-
ment and finally from their host cell to
initiate cycles of infection in red blood
cells leading to the symptoms associated
with malaria. The rate of P. falciparum
replication in hepatocytes is almost
without precedent in eukaryotic biology
and greatly exceeds the replication of
bloodstream parasite stages. There is
obvious interest in understanding how
intrahepatic Plasmodium stages achieveecember 10, 2014 ª2014 Elsevier Inc. 705
